Holliston-based Harvard Bioscience Inc. said it had adopted a shareholder rights plan.
The company said the plan “enhances its ability to protect shareholder interests and ensures that shareholders receive fair treatment in the event of any coercive takeover attempt.”
The company, which manufactures and markets medical devices, said the plan gives its board of directors time to consider alternatives to such action.
